ALTERATIONS OF GLUCOCORTICOID ACTIONS BY OTHER DRUGS AND DISEASE STATES

被引:23
作者
JUBIZ, W [1 ]
MEIKLE, AW [1 ]
机构
[1] VET ADM HOSP,SALT LAKE CITY,UT 84113
关键词
D O I
10.2165/00003495-197918020-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucocorticoids are used in physiological and pharmacological amounts in the management of a variety of clinical conditions. Concomitant utilisation of other drugs or the presence of some diseases may affect the physiological action of the steroid in the tissues. Phenytoin, phenobarbitone, ephedrine and rifampicin accelerate the metabolism of glucocorticoids thereby decreasing their biological activity. A similar phenomenon occurs in patients with hyperthyroidism. In contrast, glucocorticoid action is enhanced in hypothyroid patients and in those with hepatic damage as the result of a defect in the clearance of the hormone from blood. In turn, glucocorticoids antagonise the effects of Cholinesterase inhibitors and ganglion blocking agents. The above mentioned effects should be kept in mind whenever glucocorticoids are utilised in the diagnosis and management of endocrine or non-endocrine conditions. © 1979, ADIS Press Australasia Pty Ltd. All rights reserved.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 44 条
[1]   VALUE OF MONITORING PLASMA SALICYLATE LEVELS IN TREATING JUVENILE RHEUMATOID-ARTHRITIS - OBSERVATIONS IN 42 CASES [J].
BARDARE, M ;
CISLAGHI, GU ;
MANDELLI, M ;
SERENI, F .
ARCHIVES OF DISEASE IN CHILDHOOD, 1978, 53 (05) :381-385
[2]   PHENYTOIN INTERFERENCE WITH DEXAMETHASONE [J].
BOYLAN, JJ ;
OWEN, DS ;
CHIN, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (08) :803-804
[3]   ADVERSE EFFECTS OF PHENOBARBITAL ON CORTICOSTEROID METABOLISM IN PATIENTS WITH BRONCHIAL-ASTHMA [J].
BROOKS, SM ;
ACKERMAN, SJ ;
SULLIVAN, I ;
THRASHER, K ;
WERK, EE .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (21) :1125-&
[4]   EFFECTS OF EPHEDRINE AND THEOPHYLLINE ON DEXAMETHASONE METABOLISM IN BRONCHIAL-ASTHMA [J].
BROOKS, SM ;
SHOLITON, LJ ;
WERK, EE ;
ALTENAU, P .
JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (5-6) :308-318
[5]   CORTICOSTEROIDS IN MANAGEMENT OF SEVERE, GENERALIZED MYASTHENIA-GRAVIS - EFFECTIVENESS AND COMPARISON WITH CORTICOTROPIN THERAPY [J].
BRUNNER, NG ;
NAMBA, T ;
GROB, D .
NEUROLOGY, 1972, 22 (06) :603-&
[6]   INTERACTION OF RIFAMPIN AND GLUCOCORTICOIDS - ADVERSE EFFECT ON RENAL-ALLOGRAFT FUNCTION [J].
BUFFINGTON, GA ;
DOMINGUEZ, JH ;
PIERING, WF ;
HEBERT, LA ;
KAUFFMAN, HM ;
LEMANN, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (17) :1958-1960
[7]  
CHOI Y, 1971, J PHARMACOL EXP THER, V176, P27
[8]  
CONNEY AH, 1967, PHARMACOL REV, V19, P317
[9]   PREDNISONE OR PREDNISOLONE FOR TREATMENT OF CHRONIC ACTIVE HEPATITIS - COMPARISON OF PLASMA AVAILABILITY [J].
DAVIS, M ;
WILLIAMS, R ;
CHAKRABORTY, J ;
ENGLISH, J ;
MARKS, V ;
IDEO, G ;
TEMPINI, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (06) :501-505
[10]  
EDWARDS OM, 1974, LANCET, V2, P549